Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (Homo sapiens) | BDBM50253251 (CHEMBL4072637) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
IMED Oncology, AstraZeneca, Darwin Building, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, United Kingdom. Electronic address: bernard.barlaam2@astrazeneca.com. Curated by ChEMBL | Assay Description Inhibition of human PI4K2alpha (1 to 479 residues) by ADP Glo HTS assay | Bioorg Med Chem Lett 27: 3030-3035 (2017) Article DOI: 10.1016/j.bmcl.2017.05.028 BindingDB Entry DOI: 10.7270/Q23R0W9X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (Homo sapiens) | BDBM50253251 (CHEMBL4072637) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | 3.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
IMED Oncology, AstraZeneca, Darwin Building, Cambridge Science Park, 319 Milton Road, Cambridge CB4 0WG, United Kingdom. Electronic address: bernard.barlaam2@astrazeneca.com. Curated by ChEMBL | Assay Description Inhibition of human PIP5K2alpha (1 to 406 residues) by ADP Glo HTS assay | Bioorg Med Chem Lett 27: 3030-3035 (2017) Article DOI: 10.1016/j.bmcl.2017.05.028 BindingDB Entry DOI: 10.7270/Q23R0W9X | |||||||||||
More data for this Ligand-Target Pair |